Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc.
TRVI
Valuace
70
Růst
53
Zdraví
75
Cena
$ 11.08
Dnes
--0.28 (-2.60%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.3B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-24%
ROA
-23%
PE
-36
PS
0
Cena 1R
3-14
⌀ Cena
8.61
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
17-03-2026
Poslední dividenda

Profil

Společnost Trevi Therapeutics, Inc., biofarmaceutická společnost v klinickém stadiu, se zaměřuje na vývoj a komercializaci přípravku Haduvio pro léčbu závažných neurologicky zprostředkovaných stavů. Společnost vyvíjí Haduvio, perorální formu nalbufinu s prodlouženým uvolňováním, která je v klinické studii fáze IIb/III k léčbě chronického svědění, chronického kašle u pacientů s idiopatickou plicní fibrózou. Společnost má licenční smlouvu se společností Endo Pharmaceuticals Inc. na vývoj a prodej přípravků obsahujících hydrochlorid nalbufinu v jakékoli formě. Společnost byla založena v roce 2011 a sídlí v New Havenu v Connecticutu.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
31
Založení
2019-05-07
Adresa
195 Church Street
CEO
Jennifer L. Good

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 202520242023202220212020201920182017
Total Revenues0.000.000.000.000.000.000.000.000.000.00
Cost of Revenues31.00132.000.00123.000.000.000.000.000.000.00
Gross Profit-31.00-132.000.00-123.000.000.000.000.000.000.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.000.000.000.000.000.000.000.00176.000.00
Cost of Revenues31.000.000.000.0038.000.0038.0035.0035.0035.00
Gross Profit-31.000.000.000.00-38.000.00-38.00-35.00141.00-35.00
Operating Income TTM 202520242023202220212020201920182017
R&D Expenses0.000.000.0023,683.0019,834.0022,984.0022,328.0019,339.0014,072.006,095.00
Selling General & Admin Expenses0.000.000.0010,240.0010,073.009,492.0010,161.007,306.004,336.002,142.00
Depreciation & Amortization144.00132.00147.00123.0043.00-315.0047.0039.0023.004.00
Total Operating Expenses49,297.0049,328.0051,524.0033,923.0029,907.0032,476.0032,489.0026,645.0018,408.008,237.00
Operating Income-49,328.00-49,328.00-51,524.00-33,923.00-29,907.00-32,476.00-32,489.00-26,645.00-18,408.00-8,237.00
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.006,518.006,323.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.002,380.002,722.00
Depreciation & Amortization31.0038.0038.0037.0038.0036.0038.0035.0035.0035.00
Total Operating Expenses10,189.0013,916.0013,722.0011,470.0012,205.0014,087.0013,251.0011,871.008,898.009,045.00
Operating Income-10,220.00-13,916.00-13,722.00-11,470.00-12,243.00-14,087.00-13,289.00-11,906.00-8,933.00-9,045.00
Net Income TTM 202520242023202220212020201920182017
Interest Income6,536.006,536.003,602.004,748.001,740.0010.00178.00792.00156.0069.00
Interest Expense0.000.004.00391.00780.001,202.00456.000.00174.003,342.00
Other Expense6,506.006,505.003,583.004,826.00719.00-1,485.00-287.00577.00-2,243.00-1,376.00
IBT-42,822.00-42,823.00-47,941.00-29,097.00-29,188.00-33,961.00-32,776.00-26,068.00-20,669.00-12,886.00
Income Tax Expense-63.00-64.00-30.00-32.00-36.00-21.00-18.00-18.00-124.00-26.00
Net Income-42,759.00-42,759.00-47,911.00-29,065.00-29,152.00-33,940.00-32,758.00-26,050.00-20,545.00-12,860.00
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income1,903.002,101.001,407.001,125.00843.00826.00935.00998.001,137.001,183.00
Interest Expense0.000.000.000.001.001.001.001.004.003.00
Other Expense1,888.002,099.001,400.001,119.00844.00814.00929.00996.001,130.001,334.00
IBT-8,332.00-11,817.00-12,322.00-10,351.00-11,399.00-13,273.00-12,360.00-10,910.00-7,803.00-7,711.00
Income Tax Expense-16.00-15.00-21.00-11.0016.00-31.00-8.00-8.0018.00-13.00
Net Income-8,316.00-11,802.00-12,301.00-10,340.00-11,415.00-13,242.00-12,352.00-10,902.00-7,821.00-7,698.00
Per Share Data TTM 202520242023202220212020201920182017
EPS$0.00$0.00$0.00$-0.29$-0.45$-1.49$-1.81$-1.46$-2.29$-1.43
EPS Diluted$0.00$0.00$0.00$-0.29$-0.45$-1.49$-1.81$-1.46$-2.29$-1.43
Shares Outstanding145,502.34145,104.99101,041.5799,033.0064,541.9122,841.4818,059.0117,834.578,965.258,965.25
Diluted Shares Outstanding145,502.34145,104.99101,041.5799,033.3764,541.9122,841.4818,059.0117,834.578,965.258,965.25
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.08$-0.08
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.08$-0.08
Shares Outstanding145,502.34145,104.99130,350.39117,610.75106,009.69101,041.57101,041.5799,517.2199,485.8799,325.54
Diluted Shares Outstanding145,502.34145,104.99130,350.39117,610.75106,009.69101,041.57101,041.5799,517.2199,485.8799,325.54
Current Assets TTM 20242023202220212020201920182017
Cash And Equivalents12,963.0034,097.0032,397.0012,589.0036,830.0045,001.0057,313.0017,165.0022,020.00
Short Term Investments56,532.0073,525.0050,574.00107,921.000.000.000.000.000.00
Total Cash & ST Investments69,495.00107,622.0082,971.0012,589.0036,830.0045,001.0057,313.0017,165.0022,020.00
Accounts Receivable0.00532.000.000.00241.00265.00558.00184.0061.00
Inventory0.000.000.000.000.00895.001,604.001,396.0063.00
Other Current Assets2,634.001,274.004,576.001,311.00886.00108.0077.0042.0018.00
Total Current Assets72,129.00109,428.0087,547.00122,616.0037,957.0046,269.0059,552.0018,787.0022,162.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents56,869.00117,058.0019,374.0034,097.0016,052.0012,963.0013,811.0032,397.0025,965.0013,752.00
Short Term Investments138,058.0086,827.0083,883.0073,525.0049,441.0056,532.0059,009.0050,574.0062,903.0080,400.00
Total Cash & ST Investments194,927.00203,885.00103,257.00107,622.0065,493.0069,495.0072,820.0082,971.0088,868.0094,152.00
Accounts Receivable0.000.000.00532.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.000.00
Other Current Assets3,372.003,343.002,364.001,274.001,843.002,634.003,946.004,576.005,085.005,061.00
Total Current Assets198,299.00207,228.00105,621.00109,428.0067,336.0072,129.0076,766.0087,547.0093,953.0099,213.00
Long-Term Assets TTM 20242023202220212020201920182017
Net Property, Plant & Equipment1,408.001,229.001,559.00194.00184.00330.00430.00149.0014.00
Goodwill0.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.00
Long-Term Investments0.000.000.000.000.000.000.000.000.00
Other Long-Term Assets273.00243.00297.00205.00334.00532.0019.001,553.0052.00
Total Long-Term Assets1,681.001,472.001,856.00399.00518.00862.00449.001,702.0066.00
Total Assets73,810.00110,900.0089,403.00123,015.0038,475.0047,131.0060,001.0020,489.0022,228.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment954.001,043.001,142.001,229.001,316.001,408.001,482.001,559.001,646.001,696.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments0.000.000.000.000.000.000.000.000.000.00
Other Long-Term Assets103.0068.00241.00243.00256.00273.00311.00297.00297.0068.00
Total Long-Term Assets1,057.001,111.001,383.001,472.001,572.001,681.001,793.001,856.001,943.001,764.00
Total Assets199,356.00208,339.00107,004.00110,900.0068,908.0073,810.0078,559.0089,403.0095,896.00100,977.00
Current Liabilities TTM 20242023202220212020201920182017
Accounts Payable1,511.003,414.001,809.002,857.002,849.002,016.001,599.00603.00537.00
Short-Term Debt309.00285.00612.007,025.005,953.00113.0099.000.005,285.00
Other Current Liabilities4,932.006,810.003,403.003,518.00114.003,426.003,501.002,073.001,303.00
Current Liabilities6,752.0010,509.005,824.0013,400.0012,724.005,555.005,199.002,676.007,125.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable2,709.002,974.001,421.003,414.001,614.001,511.002,112.001,809.001,256.001,352.00
Short-Term Debt296.00286.00276.00285.00297.00309.00322.00612.00584.00554.00
Other Current Liabilities6,036.005,981.005,169.006,810.007,212.004,932.002,842.003,403.003,333.002,805.00
Current Liabilities9,041.009,241.006,866.0010,509.009,123.006,752.005,276.005,824.005,173.004,711.00
Long-Term Liabilities TTM 20242023202220212020201920182017
Long-Term Debt884.00747.001,032.002,153.008,676.0014,098.00257.000.000.00
Capital Leases884.001,032.001,338.0027.00144.00257.00356.000.000.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.00
Total Liabilities7,636.0011,256.006,856.0015,556.0021,400.0019,849.005,456.003,182.007,450.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt527.00605.00681.00747.00816.00884.00949.001,032.001,113.001,193.00
Capital Leases823.00891.00957.001,032.001,113.00884.001,271.001,032.001,405.001,470.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities9,568.009,846.007,547.0011,256.009,939.007,636.006,225.006,856.006,286.005,904.00
Total Common Equity TTM 20242023202220212020201920182017
Common Stock73.0094.0068.0060.0029.0019.0018.00101.004.00
Retained Earnings-262,388.00-287,045.00-239,134.00-210,069.00-180,917.00-146,977.00-114,219.00-109,498.00-84,432.00
Comprehensive Income-84.0061.00-29.00-122.000.000.00-60,001.00-46.00-23.00
Total Common Equity66,174.0099,644.0082,547.00107,459.0017,075.0027,282.0054,545.0017,307.0014,778.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock128.00122.00100.0094.0075.0073.0069.0068.0064.0063.00
Retained Earnings-321,488.00-309,686.00-297,385.00-287,045.00-275,630.00-262,388.00-250,036.00-239,134.00-231,313.00-223,615.00
Comprehensive Income30.0024.0073.0061.00139.00-84.00-67.00-29.00-217.00-248.00
Total Common Equity189,788.00198,493.0099,457.0099,644.0058,969.0066,174.0072,334.0082,547.0089,610.0095,073.00
Other TTM 20242023202220212020201920182017
Total Debt1,193.001,032.001,338.009,178.0014,629.0014,211.00356.000.005,285.00
Book Value66,174.0099,644.0082,547.00107,459.0017,075.0027,282.0054,545.0017,307.0014,778.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value189,788.00198,493.0099,457.0099,644.0058,969.0066,174.0072,334.0082,547.0089,610.0095,073.00
Cash Flow From Operating Activities TTM 202520242023202220212020201920182017
Net Income-38,773.00-42,759.00-47,911.00-29,065.00-29,152.00-33,940.00-32,758.00-26,050.00-20,545.00-12,860.00
Depreciation & Amortization143.00144.00147.00123.0043.0050.0047.0039.0023.004.00
Stock-Based Compensation2,914.005,185.003,588.002,247.002,327.002,543.002,417.001,127.00496.00205.00
Change Working Capital3,608.00-3,491.006,827.00-3,847.00-1,231.001,509.001,058.001,576.00-568.00722.00
Change In Accounts Receivable0.000.000.000.000.000.00293.00-374.000.000.00
Change In Accounts Payable133.00-598.001,605.00-1,049.009.00831.00417.00777.0066.0092.00
Change In Inventories0.000.000.000.000.000.00-293.00374.000.000.00
Other Non-cash Items2,089.00-1,168.00-907.00-1,168.00-162.00974.00227.00215.002,303.002,602.00
Cash from Operations-32,788.000.000.00-31,710.00-28,175.00-28,946.00-29,000.00-23,093.00-18,291.00-7,975.00
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-8,316.00-11,802.00-12,301.00-10,340.00-11,415.00-13,242.00-12,352.00-10,902.00-7,821.00-7,698.00
Depreciation & Amortization31.0038.0038.0037.0038.0036.0038.0035.0035.0035.00
Stock-Based Compensation1,350.001,243.001,384.001,208.00917.00821.001,127.00723.00534.00530.00
Change Working Capital-274.00-169.001,051.00-4,099.001,009.003,153.002,727.00-62.00736.00207.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Change In Accounts Payable123.00-282.001,554.00-1,993.001,799.00130.00-618.00294.00627.00-170.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items-422.00-190.00-273.00-283.00-99.00-324.00-223.00-261.00134.00119.00
Cash from Operations0.000.000.000.000.000.000.000.00-6,359.00-7,279.00
Cash Flow From Investing Activities TTM 202520242023202220212020201920182017
Capital Expenditure-68.00-12.00-35.00-137.00-159.000.00-32.00-9.00-158.00-13.00
Acquisitions671.000.000.000.00-829.000.000.000.000.000.00
Investments-41,173.00-170,662.00-98,463.00-9,932.00-126,215.000.000.000.000.000.00
Sales of Investment66,745.0074,929.0075,603.0069,497.0019,001.000.000.000.000.000.00
Other Investing Activities411.870.000.000.00829.000.000.000.000.000.00
Cash from Investing25,504.000.000.0059,428.00-107,373.000.00-32.00-9.00-158.00-13.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.00-12.000.000.00-7.000.00-28.000.00-22.00-18.00
Acquisitions0.000.000.000.000.000.000.000.00671.000.00
Investments-54,396.00-71,610.00-17,110.00-27,546.00-45,192.00-13,049.00-9,958.00-30,264.00-951.000.00
Sales of Investment23,621.0020,684.0014,117.0017,595.0021,327.0020,716.0012,754.0022,173.0013,818.0018,000.00
Other Investing Activities0.000.000.000.000.000.000.000.0012.8718.00
Cash from Investing0.000.000.000.000.000.000.000.0012,845.0017,982.00
Cash Flow From Financing Activities TTM 202520242023202220212020201920182017
Debt Repaid-63.060.000.00-9,504.00-5,833.000.000.00-2,239.00-5,344.00-8,250.00
Debt Issued-213.941,032.00-306.001,664.00382.00418.0013,855.002,595.0059.0013,535.00
Issuance of Common Stock61.000.000.001,710.00105,410.0021,183.003,135.0065,100.000.000.00
Repurchase of Common Stock0.000.000.000.000.000.000.00-1,213.000.000.00
Dividends Paid0.000.000.000.000.000.000.00-2,239.000.000.00
Other Financing Activities4,855.520.000.00-116.0011,730.00-408.0013,585.0013,804.008,975.0029,972.00
Cash from Financing5,040.460.000.00-7,910.00111,307.0020,775.0016,720.0073,213.003,631.0021,722.00
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.00-32.00-31.00
Debt Issued823.00-68.00-66.00-75.00-81.00-80.00-78.00-67.00-35.00-34.00
Issuance of Common Stock0.000.000.000.000.000.000.000.00-1,732.001,710.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00-22.000.00
Cash from Financing0.000.000.000.000.000.000.000.00-0.051.51
Cash position TTM 202520242023202220212020201920182017
Net Change in Cash-789.00-15,183.001,700.0019,808.00-24,241.00-8,171.00-12,312.0050,111.00-14,818.0013,734.00
Closing Cash Balance12,963.0018,914.0034,097.0032,397.0012,589.0036,830.0045,001.0057,313.007,202.0022,020.00
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-37,955.00-60,189.0097,684.00-14,723.0018,045.003,089.00-848.00-18,586.006,432.0012,213.00
Closing Cash Balance18,914.0056,869.00117,058.0019,374.0034,097.0016,052.0012,963.0013,811.0032,397.0025,965.00
Free Cash Flow TTM 202520242023202220212020201920182017
Free Cash Flow-32,856.00-42,101.00-38,291.00-31,847.00-28,334.00-28,946.00-29,032.00-23,102.00-18,449.00-7,988.00
Real Free Cash Flow-35,770.00-47,286.00-41,879.00-34,094.00-30,661.00-31,489.00-31,449.00-24,229.00-18,945.00-8,193.00
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow5,846.00-10,892.00-10,101.00-13,477.00-9,557.00-9,556.00-8,711.00-10,467.00-6,381.00-7,297.00
Real Free Cash Flow4,496.00-12,135.00-11,485.00-14,685.00-10,474.00-10,377.00-9,838.00-11,190.00-6,915.00-7,827.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-36.1-7.7-1.4
P/S0591.99.4
P/B8.13.65.2
P/FCF-45.7-7.8-1.5
Market cap$1.3$0.6
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0.4 %10.4 %0 %
Debt to Income-1.9 %-16 %0 %
Debt to Free cash flow-2.4 %-2483.9 %0 %
Interest expense percentage0 %-1.6 %44.7 %
Current ratio21.9 9.2 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-22.5 %-80.5 %0 %
ROA-21.4 %-50 %0 %
CapEx to Revenue0 %6.5 %0 %
RaD to Revenue0 %3123.3 %0 %
ROEM0.0 460.3

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %2.7 %68.7 %
Operating margin0 %-4274.4 %35.5 %
Net margin0 %-3839.7 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0.6 %0 %
Dividend payout percentage0 %-1.8 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding145.1 mil 54.0 mil
Employee count0.0 tis 0.0 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader